Literature DB >> 20054805

Expression of p53 family members and CD44 in oral squamous cell carcinoma (OSCC) in relation to tumorigenesis.

Pauline Bidaud1, Jacques Chasle, François Sichel, Stéphane Rousseau, Pascal Petit, Didier Pottier, Jean-Michel Picquenot, Marie-Yolande Louis, Mathilde Lechevrel.   

Abstract

Oral squamous cell carcinomas (OSCCs) are described as the result of a multistep tumorigenesis process. In order to develop useful diagnosis of pre-malignant lesions, expression of p53 family members and the cancer stem cell (CSCs) marker, CD44v6, were studied in histologically normal oral epithelium, precancerous lesions and succeeding invasive OSCCs. p53 was expressed focally in normal epithelium adjacent to tumors, while expression was high in intra-epithelial neoplasia and moderate in OSCC. p63 nuclear staining was important in basal and suprabasal layers of histologically normal oral mucosa and in immature compartments of premalignant lesions and cancer. In epithelium without neoplasia, intense p73 staining was observed in the basal layer, while focal expression was present in suprabasal layers. Most immature dysplastic areas showed either high or moderate staining, whereas those in OSCCs expressed low and moderate p73 level expression. CD44v6 was only expressed in poorly differentiated areas of epithelium, altered or not. p53, p63 and p73 positive stainings were statistically related in intra-epithelial neoplasia to tumours. Analysis of TP53 mutations in 17% of tumours principally revealed G>A and A>G transitions. No relation was observed between this mutational profile and different immunostainings. In conclusion, our results support that immunostaining of p53 family members might be helpful in diagnosis and monitoring of high-risk pre-malignant lesions of oral epithelium. The combination of staining patterns of p63, p73alpha and CD44v6 enabled us to isolate phenotypic undifferentiated or transient amplifying areas, reflecting the immaturity of the tumour cell lineage. While CD44v6 expression is an interesting marker of such epithelial cells, it is not specific enough to be useful alone and other phenotypic markers are needed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20054805     DOI: 10.14670/HH-25.331

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  6 in total

1.  Identification of the Potential Correlation between Tumor Protein 73 and Head and Neck Squamous Cell Carcinoma.

Authors:  Yuming Chen
Journal:  Dis Markers       Date:  2022-06-15       Impact factor: 3.464

2.  Expression of Cancer Stem Cell Biomarkers in Human Head and Neck Carcinomas: a Systematic Review.

Authors:  Raissa Borges Curtarelli; Jussara Maria Gonçalves; Luciane Geanini Pena Dos Santos; Maria Gorete Savi; Jacques Eduardo Nör; Luis André Mendonça Mezzomo; Mabel Mariela Rodríguez Cordeiro
Journal:  Stem Cell Rev Rep       Date:  2018-12       Impact factor: 5.739

Review 3.  The evolving concepts of cancer stem cells in head and neck squamous cell carcinoma.

Authors:  Amit Shah; Shilpa Patel; Jigna Pathak; Niharika Swain; Shwetha Kumar
Journal:  ScientificWorldJournal       Date:  2014-01-21

4.  Downregulation of GBAS regulates oral squamous cell carcinoma proliferation and apoptosis via the p53 signaling pathway.

Authors:  Xing Wang; Yuting Bai; Ying Han; Jian Meng; Hongwei Liu
Journal:  Onco Targets Ther       Date:  2019-05-17       Impact factor: 4.147

5.  Application of Weighted Gene Co-expression Network Analysis for Data from Paired Design.

Authors:  Jianqiang Li; Doudou Zhou; Weiliang Qiu; Yuliang Shi; Ji-Jiang Yang; Shi Chen; Qing Wang; Hui Pan
Journal:  Sci Rep       Date:  2018-01-12       Impact factor: 4.379

6.  Identification and in vitro validation of prognostic lncRNA signature in head and neck squamous cell carcinoma.

Authors:  Jian Wang; Qinjiang Bian; Jialin Liu; Adili Moming
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.